, or 5.4% increased from Q1/2018 in Baht 35.7 million of which Baht 688.3 million was revenue from sales. The Company had successfully recorded a sales growth of Baht 51.7 million, or 8.1% year-over-year
the street, in office buildings and in shopping malls. These changes have resulted in the significant growth of outdoor and online advertising and the decline of traditional media, as brands and clients
private consumption and investment. However, economic expansion remains at risk due to higher cost of living, the rising of household debts amid an upward trend of interest rates, the increasing of interest
plan regarding the expansion of biodiesel business of the Company. Details of the Board of Directors’ opinion and details of the capital increase and the allocation of the newly issued ordinary shares
’ future revenue growth and diverse business dependency risk on food and beverage industry to cosmeceuticals and medical business, which has positive expansion with consumers-oriented goodwill. (3) Increase
information. (2) Increase Group of Companies’ future revenue growth and diverse business dependency risk on food and beverage industry to cosmeceuticals and medical business, which has positive expansion with
$1.4 billion, driven by volume growth and higher margin realization. In 4Q18, core EBITDA increased by 24% YoY to $318 million, supported by higher volume. In 4Q18, core EBITDA per ton was stable
revenue growth. This promising growth was attributed by the increase of number of patients as well as bill amount per patient. Revenue growth from social security incurred from higher number of registered
in line with income from investments, an increase in net premiums earned - net, and revenue from capital market products. Nonetheless, given one extraordinary item – an increase in retirement reserves
performance are as follows: Sales Revenue Sales revenue for Q2/2017 of 269.33 million baht shows an increase of 99.98 million baht or 59.04% y-o-y. Cost of sales of 172.40 million baht shows an increase of